CLINICAL_TRIALS
trial_result
· 2020-02-13
Clinical Trial Update: Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral Monotherapy [Phase 3]
Summary
Phase III trial update for UT-15C in pulmonary arterial hypertension; study completed with results posted in 2020.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: United Therapeutics | Conditions: Pulmonary Arterial Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2020-02-13